Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)

Gayoso, JorgeBalsalobre, PascualKwon, MiSampol Mayol, AntoniaMontesinos, PauSerrano, DavidHerrera, PilarJesus Pascual, MariaBermudez, AranchaCastilla-Llorente, CristinaBento, LeyreChamp, DianaPerez-Corral, AnaBuces, ElenaLuis Diez-Martin, Jose2024-07-042024-07-042015-02Gayoso J, Balsalobre P, Kwon M, Sampol A, Montesinos P, Serrano D, et al. Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS) [meeting abstract]. Biol Blood Marrow Transplant. 2015 Feb;21(Suppl 2):S186.1083-8791http://hdl.handle.net/20.500.13003/17323http://hdl.handle.net/20.500.12105/20100BMT Tandem Meetings. San Diego, CA. FEB 11-15, 2015.enghttp://creativecommons.org/licenses/by-nc-nd/4.0/Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)conference presentationAttribution-NonCommercial-NoDerivatives 4.0 International212 (S1)S18610.1016/j.bbmt.2014.11.2831523-6536Biology of Blood and Marrow Transplantationopen access348633000245